Prospective control study of efficacy and safety of ketogenic diet on drug refractory Dravet syndrome
10.3760/cma.j.issn.2095-428X.2019.15.009
- VernacularTitle: 生酮饮食治疗药物难治性Dravet综合征的疗效和安全性的前瞻性对照研究
- Author:
Jiawen LIU
1
,
2
;
Xin DING
1
;
Yanwei ZHU
1
;
Xia ZHAO
1
;
Yan HU
1
;
Zhanqi HU
1
;
Li CHEN
1
;
Jianxiang LIAO
1
;
Dezhi CAO
1
Author Information
1. Department of Neurology, Shenzhen Children′s Hospital Affiliated to Shantou University Medical School, Shenzhen 518038, Guangdong Province, China
2. Shantou University Medical College, Shantou 515041, Guangdong Province, China
- Publication Type:Journal Article
- Keywords:
Ketogenic diet;
Antiepileptic drugs;
Dravet syndrome;
Efficacy;
Safety
- From:
Chinese Journal of Applied Clinical Pediatrics
2019;34(15):1160-1165
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the efficacy and safety of ketogenic diet (KD) and antiepileptic drugs(AEDs) in the children with drug refractory Dravet syndrome (DS).
Methods:Thirty-two cases of drug refractory DS were enrolled into the Department of Neurology, Shenzhen Children′s Hospital Affiliated to Shantou University Medical School from July 2016 to December 2017, and they were divided into 2 groups: KD group and AEDs group (16 cases for each group), respectively.KD was added to as an additional therapy for KD group, and oral AEDs were administered only in AEDs group.In KD group, oral AEDs were not adjusted for the first 3 months.AEDs could be adjusted within a limited range in 2 groups after 3 months.The clinical efficacy, improvement of cognitive function, retention rate and side effects were observed and compared after 3, 6, 12 months of treatment.The average monthly seizure frequency within 3 months before enrollment was recorded as the baseline.The clinical efficacy was assessed by comparing the seizure frequency of each observation period with the baseline.
Results:In KD group, after 3, 6, 12 months′ follow-up, KD the-rapy was maintained in 15, 14, 12 patients.The number of patients whose seizure reduction over 50% was 10, 12, 11 cases, respectively.The number of patients whose seizure reduction over 90% was 7, 9, 10 cases, respectively.The number of patients who were seizure free was 3, 6, 8 cases, respectively.In AEDs group, after 3, 6, 12 months′ therapy, the number of patients whose seizure reduction over 50% was 6, 7, 8 cases, respectively, the number of patients whose seizure reduction over 90% was 3, 3, 4 cases, respectively.The number of patients who were seizure-free was 2, 1, 2 cases, respectively.There was a significant difference in the seizure reduction between 2 groups after 6, 12 months (P<0.05). Furthermore, the incidence of status epilepticus (SE) was significantly reduced in KD group, and non-fever related status epilepticus (NFSE) was preferentially improved.There was a significant difference in the incidence of SE between before and after treatment in the KD group (P<0.05). After 12 months, there was a significant difference in the incidence of SE between 2 groups (P<0.05). After 6, 12 months of treatment, the patients in KD group had significant improvements in adaption, gross motor and language quotients by Gesell Developmental Scale compared to the AEDs group (all P<0.05). Eleven of 12 children who adhered to the therapy for 1 year in KD group had improvement of developmental quotient ≥ 1 grade, however, 7 cases of 16 children in AEDs group had this improvement.The incidence of adverse effect in the KD group and the AEDs group was 37.5%(6/16 cases) and 56.3%(9/16 cases), respectively, and the difference was not significant (P>0.05).
Conclusions:KD can not only reduce seizure frequency and relieve SE, but also improve the cognitive function of drug refractory DS.The adverse reaction ratio of KD does not increase significantly compared to AEDs.Therefore, KD is effective and safe therapy for children with drug-resistant DS.
